Johnson & Johnson to divest LifeScan unit for $2
Post# of 11802
Johnson & Johnson to divest LifeScan unit for $2.1B
Mar. 16, 2018 7:57 AM ET|About: Johnson & Johnson (JNJ)|By: Douglas W. House, SA News Editor
•Johnson & Johnson (NYSE:JNJ) announces that it has received a $2.1B binding offer from private equity shop Platinum Equity for its LIfeScan glucose monitoring business.